Drug Safety Evaluation / Pharmaceutical Development Bd.1 (PDF)
(Sprache: Englisch)
This practical guide presents a road map for safety assessment as an integral part of the development of new drugs and therapeutics.
* Helps readers solve scientific, technical, and regulatory issues in preclinical safety assessment and early clinical...
* Helps readers solve scientific, technical, and regulatory issues in preclinical safety assessment and early clinical...
sofort als Download lieferbar
eBook (pdf)
280.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Drug Safety Evaluation / Pharmaceutical Development Bd.1 (PDF)“
This practical guide presents a road map for safety assessment as an integral part of the development of new drugs and therapeutics.
* Helps readers solve scientific, technical, and regulatory issues in preclinical safety assessment and early clinical drug development
* Explains scientific and philosophical bases for evaluation of specific concerns - including local tissue tolerance, target organ toxicity and carcinogenicity, developmental toxicity, immunogenicity, and immunotoxicity
* Covers the development of new small and large molecules, generics, 505(b)(2) route NDAs, and biosimilars
* Revises material to reflect new drug products (small synthetic, large proteins and cells, and tissues), harmonized global and national regulations, and new technologies for safety evaluation
* Adds almost 20% new and thoroughly updates existing content from the last edition
* Helps readers solve scientific, technical, and regulatory issues in preclinical safety assessment and early clinical drug development
* Explains scientific and philosophical bases for evaluation of specific concerns - including local tissue tolerance, target organ toxicity and carcinogenicity, developmental toxicity, immunogenicity, and immunotoxicity
* Covers the development of new small and large molecules, generics, 505(b)(2) route NDAs, and biosimilars
* Revises material to reflect new drug products (small synthetic, large proteins and cells, and tissues), harmonized global and national regulations, and new technologies for safety evaluation
* Adds almost 20% new and thoroughly updates existing content from the last edition
Autoren-Porträt von Shayne Cox Gad
Shayne Cox Gad, BS, PhD, DABT, has more than 39 years of experience in regulatory toxicology, drug and device development, statistics, and risk assessment. He is Principal of Gad Consulting Services, a firm with eight employees and more than 500 clients worldwide in the pharmaceutical and medical device industries. He is Past President of the American College of Toxicology (ACT), the Roundtable of Toxicology Consultants, and three of the Society of Toxicology's specialty sections. Dr. Gad received the 2008 ACT Lifetime Contribution Award and has authored or edited 47 books (10 with Wley) and more than 350 chapters, articles, and abstracts. Has preparated 110 INDs and 8 NDAs and teaches 3-5 professional education courses a year.
Bibliographische Angaben
- Autor: Shayne Cox Gad
- 2016, 3. Auflage, 918 Seiten, Englisch
- Verlag: John Wiley & Sons
- ISBN-10: 1119097401
- ISBN-13: 9781119097402
- Erscheinungsdatum: 18.11.2016
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Größe: 6.87 MB
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Drug Safety Evaluation / Pharmaceutical Development Bd.1"
0 Gebrauchte Artikel zu „Drug Safety Evaluation / Pharmaceutical Development Bd.1“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Drug Safety Evaluation / Pharmaceutical Development Bd.1".
Kommentar verfassen